What are the number needed to harm and number needed to treat with Romosozumab for cardiovascular risk and osteoporosis benefit, respectively?
Romosozumab presents a number needed to treat (NNT) of approximately 35 for preventing major osteoporotic fractures, while the number needed to harm (NNH) for cardiac events ranges from 125 to 206, highlighting a need for careful patient selection and monitoring for cardiovascular risks.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5281/zenodo.24207504
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00